ATE145727T1 - Hybridoma ct43, das ein antikörper gegen ein mucinepitop von darmkrebs erzeugt - Google Patents

Hybridoma ct43, das ein antikörper gegen ein mucinepitop von darmkrebs erzeugt

Info

Publication number
ATE145727T1
ATE145727T1 AT90915238T AT90915238T ATE145727T1 AT E145727 T1 ATE145727 T1 AT E145727T1 AT 90915238 T AT90915238 T AT 90915238T AT 90915238 T AT90915238 T AT 90915238T AT E145727 T1 ATE145727 T1 AT E145727T1
Authority
AT
Austria
Prior art keywords
antigenic determinant
antigen
mucinepitop
hybridoma
produces
Prior art date
Application number
AT90915238T
Other languages
English (en)
Inventor
Joseph P Brown
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Application granted granted Critical
Publication of ATE145727T1 publication Critical patent/ATE145727T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Microscoopes, Condenser (AREA)
  • Exposure And Positioning Against Photoresist Photosensitive Materials (AREA)
  • Exposure Of Semiconductors, Excluding Electron Or Ion Beam Exposure (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90915238T 1989-09-15 1990-09-10 Hybridoma ct43, das ein antikörper gegen ein mucinepitop von darmkrebs erzeugt ATE145727T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40751389A 1989-09-15 1989-09-15

Publications (1)

Publication Number Publication Date
ATE145727T1 true ATE145727T1 (de) 1996-12-15

Family

ID=23612390

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90915238T ATE145727T1 (de) 1989-09-15 1990-09-10 Hybridoma ct43, das ein antikörper gegen ein mucinepitop von darmkrebs erzeugt

Country Status (8)

Country Link
US (1) US5459043A (de)
EP (1) EP0491867B1 (de)
JP (1) JP3137976B2 (de)
AT (1) ATE145727T1 (de)
AU (1) AU656716B2 (de)
CA (1) CA2065874C (de)
DE (1) DE69029270T2 (de)
WO (1) WO1991004490A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7373587B1 (en) 1990-06-25 2008-05-13 Barstow David R Representing sub-events with physical exertion actions
JP3151054B2 (ja) * 1992-06-25 2001-04-03 協和醗酵工業株式会社 抗ｄｃｃ遺伝子産物モノクローナル抗体
SE9500148D0 (sv) * 1995-01-18 1995-01-18 Bioinvent Internatioal Ab Antibodies for use in cancer therapy and diagnosis
US20040235072A1 (en) * 1998-03-18 2004-11-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7579160B2 (en) * 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
IL139700A (en) * 1998-06-15 2005-09-25 Altarex Medical Corp Immunotherapeutic composition for the treatment of prostate cancer
KR100643818B1 (ko) * 2000-05-08 2006-11-10 셀덱스 쎄라퓨틱스, 인크. 수상세포에 대한 인간 모노클로날 항체
WO2003027138A1 (en) * 2001-09-25 2003-04-03 Japan As Represented By President Of National Cancer Center Search for cancer marker by novel screening method
JP2014521958A (ja) 2011-07-28 2014-08-28 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 胸腔内液若しくは漿液と関連する腫瘍細胞の特徴づけによる癌の診断方法
US20150231077A1 (en) 2014-02-17 2015-08-20 The Cleveland Clinic Foundation Amine passivated nanoparticles for cancer treatment and imaging
CN109856400B (zh) * 2019-01-22 2022-02-01 上海交通大学医学院附属仁济医院 神经酰胺c24作为生物标记物在诊断胆囊癌中的用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
US4486530A (en) * 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4762800A (en) * 1984-04-26 1988-08-09 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to cell surface antigens of human teratocarcinomas
NZ212419A (en) * 1984-06-25 1988-08-30 Mucan Diagnostics Pty Ltd In vitro diagnostic test for detecting cancer cells producing mucin antigens
ES8800604A1 (es) * 1985-04-22 1987-11-16 Hybritech Inc Un metodo para producir anticuerpos monoclonales
US4863854A (en) * 1985-08-12 1989-09-05 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to mucin-like human differentiation antigens
US4743543A (en) * 1985-09-09 1988-05-10 Coulter Corporation Method for enhancing and/or accelerating immunoassay detection of human carcinoma tumor associated antigen in a pathology sample
US4803169A (en) * 1986-02-05 1989-02-07 Cetus Corporation Assay for human breast cancer
US4900684A (en) * 1987-06-01 1990-02-13 Immunomedics, Inc. CEA immunoassay free of human anti-mouse antibody false positives
CA1340927C (en) * 1987-10-09 2000-03-14 Peter S. Linsley Method for increasing the sensitivity of assays for target ligand
DE3850046D1 (de) * 1987-11-20 1994-07-14 Abbott Lab Nachweis von Tumorassozierten Anzeigern in biologischen Flüssigkeiten.
US4763854A (en) * 1988-02-23 1988-08-16 A. Johnson Metals Corporation Container for continuous supply of wire
US4921789A (en) * 1988-04-20 1990-05-01 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same

Also Published As

Publication number Publication date
JPH05500454A (ja) 1993-02-04
CA2065874A1 (en) 1991-03-16
EP0491867A1 (de) 1992-07-01
EP0491867B1 (de) 1996-11-27
CA2065874C (en) 2001-12-11
JP3137976B2 (ja) 2001-02-26
DE69029270T2 (de) 1997-03-27
DE69029270D1 (de) 1997-01-09
AU6506290A (en) 1991-04-18
WO1991004490A1 (en) 1991-04-04
US5459043A (en) 1995-10-17
AU656716B2 (en) 1995-02-16
EP0491867A4 (en) 1993-05-05

Similar Documents

Publication Publication Date Title
MX9701859A (es) Anticuerpos monoclonales en contra de antigenos asociados con carcinoma de colon humano, y usos de los mismos.
DE69029270D1 (de) HYBRIDOMA CT43, DAS EIN ANTIKöRPER GEGEN EIN MUCINEPITOP VON DARMKREBS ERZEUGT
EP0517815A4 (en) An igg-1 human monoclonal antibody reactive with an hiv-1 glycoprotein and method of use
EP0268279A3 (de) Hybridome, die monoklonale Antikörper gegen neue Mucin-Epitope produzieren
UA40577C2 (uk) Біспецифічна молекула, що використовується для лізису пухлинних клітин, спосіб її одержання, моноклональне антитіло (варіанти), фармацевтичний препарат, фармацевтичний набір (варіанти), спосіб видалення пухлинних клітин
EP0597829A4 (de) Monoklonaler antikörper gegen einen neuen mit menschlichen tumoren assoziierten antigen.
ES8606901A1 (es) Procedimiento para preparar una vacuna contra la coccidiosis
DE69331703D1 (de) B-lymphomazellinie und antigen
ATE327330T1 (de) Rekombinante humanisierte antikörper gegen fb5
IL116617A0 (en) Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples
ATE242807T1 (de) Monoklonaler antikörper gegen ein humanes mdr1- gen produkt, das eine resistenz gegen verschiedene medikamente erzeugt und seine verwendung
MX9605895A (es) Anticuerpos monoclonales humanos especificos para antigeno de superficie de glioma independiente del ciclo celular.
CA1241924A (en) MONOCLONAL ANTIBODY AND ANTIGEN REAGENTS AGAINST MEROZOITES OF EIMERIA SPP.
NO950325D0 (no) Immunanalyse for påvisning av kollagen eller kollagenfragmenter
DE69132122D1 (de) Reinigung von cytokeratinfragmenten
EP0675728A4 (de) Mitteln und methoden zur verbesserung der keratinoyztenadhäsion an der haut.
DK0466818T3 (da) Monoklonalt antistof der genkender et glycoprotein fra mucin-antigen fra membranen af fedtkugler fra human mælk
ATE185196T1 (de) Nachweisverfahren von tumorassoziierten antigenen
ES2082017T3 (es) Anticuerpo monoclonal que reconoce el epitopo especifico de glucosidos de antraciclina e hibridoma que secreta dicho anticuerpo.
EP0297930A3 (de) Monoklonale Antikörper
KR890701633A (ko) 호중구 및 호산구의 공통 결정부위에 특이적인 단일 클론 항체
SE9904236D0 (sv) Immunoassay
TW288020B (en) Monoclonal antibodies specific to methamphetamine, hybridoma producing the antibodies, kits containing the antibodies and uses thereof
BG49666A1 (en) Hybridom cell line, secreting monoclonal antibody against determinant 027 salmonelli of group b
CO5060487A1 (es) Anticuerpos anti-idiotipos contra anticuerpos que reconocen gangliosidos portadores de acido sialico n-glicolilado y com posiciones que los contienen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties